Alfred Penfornis

Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells.

A. Penfornis, P. Saas, S. Perruche, 2012, Diabetes & metabolism.

Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.

E. Renard, A. Penfornis, P. Benhamou, 2012, Diabetes & metabolism.

Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?

A. Vambergue, C. Fagour, G. Charpentier, 2014, Diabetes & metabolism.

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study

S. Dejager, B. Fiquet, A. Penfornis, 2015, Diabetes, metabolic syndrome and obesity : targets and therapy.

Efficacy and safety of an insulin infusion protocol during and after cardiac surgery.

S. Pili-Floury, J. Etievent, A. Cordier, 2010, Diabetes & metabolism.

Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS study.

S. Dejager, S. Quéré, Isabelle Bourdel-Marchasson, 2012, Diabetes & metabolism.

Natural history, prognosis, and management of transplantation-induced diabetes mellitus.

A. Penfornis, P. Benhamou, Pierre-Yves Benhamou, 2002, Diabetes & metabolism.

Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials

E. Renard, T. Berney, P. Morel, 2009, Diabetic medicine : a journal of the British Diabetic Association.